Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2000 May 4;66(6):1777–1786. doi: 10.1086/302925

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

V Koprivica 1, D L Stone 1, J K Park 1, M Callahan 1, A Frisch 1, I J Cohen 1, N Tayebi 1, E Sidransky 1
PMCID: PMC1378059  PMID: 10796875

Abstract

Gaucher disease results from the inherited deficiency of the enzyme glucocerebrosidase (EC 3.2.1.45). Although >100 mutations in the gene for human glucocerebrosidase have been described, most genotype-phenotype studies have focused upon screening for a few common mutations. In this study, we used several approaches-including direct sequencing, Southern blotting, long-template PCR, restriction digestions, and the amplification refraction mutation system (ARMS)-to genotype 128 patients with type 1 Gaucher disease (64 of Ashkenazi Jewish ancestry and 64 of non-Jewish extraction) and 24 patients with type 3 Gaucher disease. More than 97% of the mutant alleles were identified. Fourteen novel mutations (A90T, N117D, T134I, Y135X, R170C, W184R, A190T, Y304X, A341T, D399Y, c.153-154insTACAGC, c.203-204insC, c.222-224delTAC, and c.1122-1123insTG) and many rare mutations were detected. Recombinant alleles were found in 19% of the patients. Although 93% of the mutant alleles in our Ashkenazi Jewish type 1 patients were N370S, c.84-85insG, IVS2+1G-->A or L444P, these four mutations accounted for only 49% of mutant alleles in the non-Jewish type 1 patients. Genotype-phenotype correlations were attempted. Homozygosity or heterozygosity for N370S resulted in type 1 Gaucher disease, whereas homozygosity for L444P was associated with type 3. Genotype L444P/recombinant allele resulted in type 2 Gaucher disease, and homozygosity for a recombinant allele was associated with perinatal lethal disease. The phenotypic consequences of other mutations, particularly R463C, were more inconsistent. Our results demonstrate a high rate of mutation detection, a large number of novel and rare mutations, and an accurate assessment of the prevalence of recombinant alleles. Although some genotype-phenotype correlations do exist, other genetic and environmental factors must also contribute to the phenotypes encountered, and we caution against relying solely upon genotype for prognostic or therapeutic judgements.

Full Text

The Full Text of this article is available as a PDF (412.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamov A., Elstein D., Gross-Tsur V., Farber B., Glaser Y., Hadas-Halpern I., Ronen S., Tafakjdi M., Horowitz M., Zimran A. Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet. 1995 Oct 14;346(8981):1000–1003. doi: 10.1016/s0140-6736(95)91688-1. [DOI] [PubMed] [Google Scholar]
  2. Amaral O., Lacerda L., Marcão A., Pinto E., Tamagnini G., Sá Miranda M. C. Homozygosity for two mild glucocerebrosidase mutations of probable Iberian origin. Clin Genet. 1999 Jul;56(1):100–102. doi: 10.1034/j.1399-0004.1999.560117.x. [DOI] [PubMed] [Google Scholar]
  3. Amaral O., Lacerda L., Santos R., Pinto R. A., Aerts H., Sa Miranda M. C. Type 1 Gaucher disease: molecular, biochemical, and clinical characterization of patients from northern Portugal. Biochem Med Metab Biol. 1993 Feb;49(1):97–107. doi: 10.1006/bmmb.1993.1011. [DOI] [PubMed] [Google Scholar]
  4. Azuri J., Elstein D., Lahad A., Abrahamov A., Hadas-Halpern I., Zimran A. Asymptomatic Gaucher disease implications for large-scale screening. Genet Test. 1998;2(4):297–299. doi: 10.1089/gte.1998.2.297. [DOI] [PubMed] [Google Scholar]
  5. Beutler E., Gelbart T. Gaucher disease mutations in non-Jewish patients. Br J Haematol. 1993 Oct;85(2):401–405. doi: 10.1111/j.1365-2141.1993.tb03185.x. [DOI] [PubMed] [Google Scholar]
  6. Beutler E., Gelbart T., Kuhl W., Zimran A., West C. Mutations in Jewish patients with Gaucher disease. Blood. 1992 Apr 1;79(7):1662–1666. [PubMed] [Google Scholar]
  7. Choy F. Y., Wei C., Levin D. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells. Am J Med Genet. 1996 Oct 28;65(3):184–189. doi: 10.1002/(SICI)1096-8628(19961028)65:3<184::AID-AJMG3>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  8. Choy F. Y., Wong K., Shi H. P. Glucocerebrosidase mutations among Chinese neuronopathic and non-neuronopathic Gaucher disease patients. Am J Med Genet. 1999 Jun 11;84(5):484–486. doi: 10.1002/(sici)1096-8628(19990611)84:5<484::aid-ajmg14>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  9. Cox T. M., Schofield J. P. Gaucher's disease: clinical features and natural history. Baillieres Clin Haematol. 1997 Dec;10(4):657–689. doi: 10.1016/s0950-3536(97)80033-9. [DOI] [PubMed] [Google Scholar]
  10. Dahl N., Lagerström M., Erikson A., Pettersson U. Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet. 1990 Aug;47(2):275–278. [PMC free article] [PubMed] [Google Scholar]
  11. Díaz A., Montfort M., Cormand B., Zeng B., Pastores G. M., Chabás A., Vilageliu L., Grinberg D. Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago. Am J Hum Genet. 1999 Apr;64(4):1233–1238. doi: 10.1086/302341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Erikson A. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand Suppl. 1986;326:1–42. [PubMed] [Google Scholar]
  13. Estivill X. Complexity in a monogenic disease. Nat Genet. 1996 Apr;12(4):348–350. doi: 10.1038/ng0496-348. [DOI] [PubMed] [Google Scholar]
  14. Eto Y., Ida H. Clinical and molecular characteristics of Japanese Gaucher disease. Neurochem Res. 1999 Feb;24(2):207–211. doi: 10.1023/a:1022553819241. [DOI] [PubMed] [Google Scholar]
  15. Germain D. P., Puech J. P., Caillaud C., Kahn A., Poenaru L. Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease. Am J Hum Genet. 1998 Aug;63(2):415–427. doi: 10.1086/301969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grabowski G. A. Gaucher disease: gene frequencies and genotype/phenotype correlations. Genet Test. 1997;1(1):5–12. doi: 10.1089/gte.1997.1.5. [DOI] [PubMed] [Google Scholar]
  17. Grabowski G. A., Horowitz M. Gaucher's disease: molecular, genetic and enzymological aspects. Baillieres Clin Haematol. 1997 Dec;10(4):635–656. doi: 10.1016/s0950-3536(97)80032-7. [DOI] [PubMed] [Google Scholar]
  18. Grace M. E., Ashton-Prolla P., Pastores G. M., Soni A., Desnick R. J. Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease. J Clin Invest. 1999 Mar;103(6):817–823. doi: 10.1172/JCI5168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Grace M. E., Desnick R. J., Pastores G. M. Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients. J Clin Invest. 1997 May 15;99(10):2530–2537. doi: 10.1172/JCI119437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gürakan F., Terzioğlu M., Koçak N., Yüce A., Ozen H., Ciliv G., Emre S. Analysis of three mutations in Turkish children with Gaucher disease. J Inherit Metab Dis. 1999 Dec;22(8):947–948. doi: 10.1023/a:1005668230365. [DOI] [PubMed] [Google Scholar]
  21. Hatton C. E., Cooper A., Whitehouse C., Wraith J. E. Mutation analysis in 46 British and Irish patients with Gaucher's disease. Arch Dis Child. 1997 Jul;77(1):17–22. doi: 10.1136/adc.77.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hodanová K., Hrebícek M., Cervenková M., Mrázová L., Vepreková L., Zemen J. Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles. Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):287–298. [PubMed] [Google Scholar]
  23. Horowitz M., Wilder S., Horowitz Z., Reiner O., Gelbart T., Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989 Jan;4(1):87–96. doi: 10.1016/0888-7543(89)90319-4. [DOI] [PubMed] [Google Scholar]
  24. Ida H., Rennert O. M., Iwasawa K., Kobayashi M., Eto Y. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation. Hum Genet. 1999 Jul-Aug;105(1-2):120–126. doi: 10.1007/s004399900076. [DOI] [PubMed] [Google Scholar]
  25. Kawame H., Maekawa K., Eto Y. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes. Hum Mutat. 1993;2(5):362–367. doi: 10.1002/humu.1380020507. [DOI] [PubMed] [Google Scholar]
  26. Kim J. W., Liou B. B., Lai M. Y., Ponce E., Grabowski G. A. Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations. Hum Mutat. 1996;7(3):214–218. doi: 10.1002/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  27. Lau E. K., Tayebi N., Ingraham L. J., Winfield S. L., Koprivica V., Stone D. L., Zimran A., Ginns E. I., Sidransky E. Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease. Hum Genet. 1999 Apr;104(4):293–300. doi: 10.1007/s004390050957. [DOI] [PubMed] [Google Scholar]
  28. Laubscher K. H., Glew R. H., Lee R. E., Okinaka R. T. Use of denaturing gradient gel electrophoresis to identify mutant sequences in the beta-glucocerebrosidase gene. Hum Mutat. 1994;3(4):411–415. doi: 10.1002/humu.1380030418. [DOI] [PubMed] [Google Scholar]
  29. Mistry P. K., Smith S. J., Ali M., Hatton C. S., McIntyre N., Cox T. M. Genetic diagnosis of Gaucher's disease. Lancet. 1992 Apr 11;339(8798):889–892. doi: 10.1016/0140-6736(92)90928-v. [DOI] [PubMed] [Google Scholar]
  30. Morimoto S., Yamamoto Y., O'Brien J. S., Kishimoto Y. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Proc Natl Acad Sci U S A. 1990 May;87(9):3493–3497. doi: 10.1073/pnas.87.9.3493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nilsson O., Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem. 1982 Sep;39(3):709–718. doi: 10.1111/j.1471-4159.1982.tb07950.x. [DOI] [PubMed] [Google Scholar]
  32. Ohashi T., Hong C. M., Weiler S., Tomich J. M., Aerts J. M., Tager J. M., Barranger J. A. Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem. 1991 Feb 25;266(6):3661–3667. [PubMed] [Google Scholar]
  33. Pasmanik-Chor M., Madar-Shapiro L., Stein E. O., Aerts H., Gatt S., Horowitz M. Expression of mutated glucocerebrosidase alleles in human cells. Hum Mol Genet. 1997 Jun;6(6):887–895. doi: 10.1093/hmg/6.6.887. [DOI] [PubMed] [Google Scholar]
  34. Perlmutter D. H. Alpha-1-antitrypsin deficiency. Semin Liver Dis. 1998;18(3):217–225. doi: 10.1055/s-2007-1007158. [DOI] [PubMed] [Google Scholar]
  35. Pàmpols T., Pineda M., Girós M. L., Ferrer I., Cusi V., Chabás A., Sanmarti F. X., Vanier M. T., Christomanou H. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Acta Neuropathol. 1999 Jan;97(1):91–97. doi: 10.1007/s004010050960. [DOI] [PubMed] [Google Scholar]
  36. Scriver C. R., Waters P. J. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet. 1999 Jul;15(7):267–272. doi: 10.1016/s0168-9525(99)01761-8. [DOI] [PubMed] [Google Scholar]
  37. Sidransky E., Bottler A., Stubblefield B., Ginns E. I. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype? Hum Mutat. 1994;3(1):25–28. doi: 10.1002/humu.1380030105. [DOI] [PubMed] [Google Scholar]
  38. Stone D. L., Tayebi N., Orvisky E., Stubblefield B., Madike V., Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat. 2000;15(2):181–188. doi: 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  39. Tayebi N., Cushner S., Sidransky E. Differentiation of the glucocerebrosidase gene from pseudogene by long-template PCR: implications for Gaucher disease. Am J Hum Genet. 1996 Sep;59(3):740–741. [PMC free article] [PubMed] [Google Scholar]
  40. Tayebi N., Reissner K. J., Lau E. K., Stubblefield B. K., Klineburgess A. C., Martin B. M., Sidransky E. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease. Pediatr Res. 1998 May;43(5):571–578. doi: 10.1203/00006450-199805000-00003. [DOI] [PubMed] [Google Scholar]
  41. Tayebi N., Stern H., Dymarskaia I., Herman J., Sidransky E. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles. Am J Med Genet. 1996 Dec 18;66(3):316–319. doi: 10.1002/(SICI)1096-8628(19961218)66:3<316::AID-AJMG15>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  42. Tayebi N., Stone D. L., Sidransky E. Type 2 gaucher disease: an expanding phenotype. Mol Genet Metab. 1999 Oct;68(2):209–219. doi: 10.1006/mgme.1999.2918. [DOI] [PubMed] [Google Scholar]
  43. Timms K. M., Bondeson M. L., Ansari-Lari M. A., Lagerstedt K., Muzny D. M., Dugan-Rocha S. P., Nelson D. L., Pettersson U., Gibbs R. A. Molecular and phenotypic variation in patients with severe Hunter syndrome. Hum Mol Genet. 1997 Mar;6(3):479–486. doi: 10.1093/hmg/6.3.479. [DOI] [PubMed] [Google Scholar]
  44. Uyama E., Uchino M., Ida H., Eto Y., Owada M. D409H/D409H genotype in Gaucher-like disease. J Med Genet. 1997 Feb;34(2):175–175. doi: 10.1136/jmg.34.2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Winfield S. L., Tayebi N., Martin B. M., Ginns E. I., Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res. 1997 Oct;7(10):1020–1026. doi: 10.1101/gr.7.10.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zimmer K. P., le Coutre P., Aerts H. M., Harzer K., Fukuda M., O'Brien J. S., Naim H. Y. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation). J Pathol. 1999 Aug;188(4):407–414. doi: 10.1002/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES